chitosan has been researched along with Dyslipidemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; He, H; Jiang, Y; Luo, X; Wang, C; Wang, N; Wang, Q; Zhang, T | 1 |
| Cheng, G; Du, Y; Feng, C; Jiao, S; Liu, H; Yin, H; Yuan, X; Zhao, X; Zheng, J | 1 |
| Al-Rasadi, K; Katsiki, N; Nikolic, D; Patti, AM; Rizzo, M | 1 |
| Belcaro, G; Cesarone, MR; Cornelli, M; Cornelli, U | 1 |
1 review(s) available for chitosan and Dyslipidemia
| Article | Year |
|---|---|
Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan.
Topics: Animals; Biomarkers; Cardiovascular Diseases; Chitosan; Dietary Fiber; Dietary Supplements; Dyslipidemias; Humans; Hypolipidemic Agents; Lipids; Risk Factors; Treatment Outcome | 2015 |
1 trial(s) available for chitosan and Dyslipidemia
| Article | Year |
|---|---|
Use of polyglucosamine and physical activity to reduce body weight and dyslipidemia in moderately overweight subjects.
Topics: Adult; Anticholesteremic Agents; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Chitosan; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Overweight; Treatment Outcome; Triglycerides; Waist Circumference; Weight Loss | 2008 |
2 other study(ies) available for chitosan and Dyslipidemia
| Article | Year |
|---|---|
Chitooligosaccharides Modulate Glucose-Lipid Metabolism by Suppressing SMYD3 Pathways and Regulating Gut Microflora.
Topics: Animals; Chitosan; Diabetes Mellitus, Type 2; Dysbiosis; Dyslipidemias; Gastrointestinal Microbiome; Glucose; Hep G2 Cells; Histone-Lysine N-Methyltransferase; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperglycemia; Hyperlipidemias; Kidney; Lipid Metabolism; Lipogenesis; Liver; Male; Mice; Oligosaccharides | 2020 |
Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice.
Topics: Animals; Blood Glucose; Body Composition; Chitosan; Diabetes Mellitus, Experimental; Dysbiosis; Dyslipidemias; Enzyme Activation; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Oligosaccharides; p38 Mitogen-Activated Protein Kinases | 2018 |